NFKB1 and fatty liver disease: Thus, our findings suggest that ablation of Redd1 in the whole body or adipocytes, but not in myeloid cells, prevents HFD-induced hepatic steatosis by suppressing atypical NF-κB-dependent lipogenesis rather than meta-inflammation.